Unparalleled Market Visibility with Real-Time Insights for Healthcare Investors

Guidepoint Qsight offers institutional investors exclusive, near-real-time quantitative insights into the MedTech market. We deliver highly accurate and timely revenue projections and performance tracking from the industry’s largest datasets.

Young student taking notes while e-learning on laptop at the university.

Healthcare Investors

Empower Your Healthcare Investment Decisions with Our Advanced Data Analytics Suite

Built specifically for Investors and based on the latest and most robust healthcare data, Qsight Alpha consistently outperforms consensus, offering action-oriented insights into the performance and anticipated revenues of companies in the MedTech and Aesthetics sectors.

Accurate, Timely Total Market Visibility

Provides investors with essential, up-to-date insights into the Medical Device sector, highlighting key trends and performance metrics across manufacturers, brands, and products.

Revenue and Sales Trends

Supplies highly accurate revenue insights for individual companies using the industry’s leading proprietary datasets, helping investors adjust their strategies accordingly.

Product Performance Evaluation

Tracks product-level purchasing across various healthcare facility types, providing investors with critical insights into new product launches, market demand, and product adoption rates.

Explore Our Product Offerings Designed Specifically for Healthcare Investors

Alpha

Institutional investors gain unparalleled visibility into the performance and anticipated revenues of MedTech companies via proprietary, validated models built from transactional healthcare data.

Alpha Medical Device

Access timely U.S. sales projections for 30+ publicly traded companies in the MedTech space based on purchasing data from 3,500 U.S. healthcare facilities.

Alpha DME

Access product-level, pharmacy-level, purchase order data capturing over $2.3B per year in medical equipment, devices, and supplies purchased by over 5,000 U.S. Durable Medical Equipment (DME) pharmacy locations.

Alpha Aesthetics

Access manufacturer product-level point-of-sale data capturing medical aesthetics practices’ products and treatments from over 3,500 aesthetics locations.

Alpha Quant

Access transactional healthcare data purchasing insights from 3,500+ hospitals, health systems, surgery centers and other facilities including 120+ public medical device and supply companies, delivered as a data feed and updated weekly.

Learn More

Business partners working on digital tablet in modern office

FAQs: How We Can Help Healthcare Investors

How does Guidepoint Qsight assist investors in making informed decisions in the MedTech sector?

Guidepoint Qsight provides investors with detailed data and insights, combining real-time transaction data and market projections to help assess company performances and enhance visibility in the MedTech sector.

How does Qsight provide accurate and timely market projections for MedTech investors?

Qsight ensures accurate and timely market projections by analyzing transactional data from U.S. healthcare facilities, offering precise insights into market dynamics to inform investment decisions.

What kind of product performance evaluation does Qsight offer?

Qsight tracks product-level performance at a variety of healthcare facility types, offering investors critical insights into product success, market adoption rates, and competitive positioning across Medical Device, HME/DME, and Aesthetics sectors.

Contact

Request a Demo Today

At Guidepoint Qsight, we empower decisions through unmatched, data-driven insights for the Aesthetics and MedTech industries. Send us your contact information today, and we’ll be in touch to discuss your concerns and overall needs. When it comes to data analytics, we’re the experts you can count on.

Blog

Young Gen Z woman smiling next to a Botox needle, representing Gen Z in the aesthetics industry

The Preventive Era Is Here: What 2025 Gen Z Aesthetics Data Shows

Gen Z has been one of the most-discussed cohorts in medical aesthetics for the better part of a decade. Their share of the patient population has grown steadily, and their preference for preventive care has been widely noted. But now that the oldest among them are entering their late 20s, there’s a growing interest in how these patients actually move…

April 6, 2026